MEDICATE INTERNATIONAL PRIVATE LIMITEDMEDICATE INTERNATIONAL PRIVATE LIMITED
MEDICATE INTERNATIONAL PRIVATE LIMITEDMEDICATE INTERNATIONAL PRIVATE LIMITED
MEDICATE INTERNATIONAL PRIVATE LIMITED
MEDICATE INTERNATIONAL PRIVATE LIMITED
MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED
MEDICATE INTERNATIONAL PRIVATE LIMITED
MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED MEDICATE INTERNATIONAL PRIVATE LIMITED
Home » Our Products » Xtrant

Xtrant



Description
X-trant is used in the palliative treatment of metastatic/progressive carcinoma of prostate, and ensures complete hormonal as well as cytotoxic control. While ensuring reduction in the intensity of pain, and absence of hepatic and renal toxicity, X-trant is a unique anti-tumor agent and its usage would improve performance status of patients suffering from prostate cancer.

The medicine is also useful in patients with limited bone marrow reserve. X-trant has a dual mode of action. Structurally, X-trant (estramustine) would be a phosphorylated combination of estradiol and mechlorethamine (nitrogen mustard).

The intact molecule acts as an antimitotic agent. It binds to a protein present in the tumor tissue which results in an accumulation of the drug at the target site. NATCO's X-trant ensures not only availability of the drug, but also at an affordable price.


Note: Xtrant is a prescription drug and should be used under proper medical guidance and advice.
Do not share the medicine with others, since they may be suffering from a problem that is not effectively treated by this drug.